
    
      The study will be conducted at multiple study centers in the U.S. Subjects will be enrolled
      in the trial for a period of 44 days. The study will consist of a screening period lasting up
      to 30 days, a device fitting period of 14 days, and a treatment period lasting 30 days.
      Subjects will visit the clinic three times during the screening period, followed by visits at
      Day 1, Day 14, and Day 44 of the study. Subjects will visit the sleep center once during the
      screening period (Day -1) and once during the treatment period (Day 43).
    
  